Filing Details
- Accession Number:
- 0000200406-10-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-14 18:18:36
- Reporting Period:
- 2010-09-10
- Filing Date:
- 2010-09-14
- Accepted Time:
- 2010-09-14 18:18:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189000 | C Russell Deyo | Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common | Disposition | 2010-03-15 | 3,005 | $0.00 | 122,088 | No | 4 | G | Direct | |
Common | Acquisiton | 2010-09-10 | 1,900 | $50.69 | 123,988 | No | 4 | M | Direct | |
Common | Acquisiton | 2010-09-10 | 168,100 | $50.69 | 292,088 | No | 4 | M | Direct | |
Common | Disposition | 2010-09-10 | 155,300 | $59.83 | 136,788 | No | 4 | S | Direct | |
Common | Acquisiton | 2010-08-31 | 305 | $0.00 | 6,739 | No | 5 | J | Indirect | Johnson & Johnson Stock Fund under the 401(k) Savings Plan |
Common | Acquisiton | 2010-03-15 | 1,585 | $0.00 | 10,771 | No | 5 | G | Indirect | By Wife |
Common | Acquisiton | 2010-03-15 | 340 | $0.00 | 2,357 | No | 5 | G | Indirect | By Daughter |
Common | Acquisiton | 2010-03-15 | 340 | $0.00 | 2,739 | No | 5 | G | Indirect | By Son |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 5 | J | Indirect | Johnson & Johnson Stock Fund under the 401(k) Savings Plan |
No | 5 | G | Indirect | By Wife |
No | 5 | G | Indirect | By Daughter |
No | 5 | G | Indirect | By Son |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2010-09-10 | 1,900 | $0.00 | 1,900 | $50.69 |
Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2010-09-10 | 168,100 | $0.00 | 168,100 | $50.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-11-30 | 2010-11-29 | No | 4 | M | Direct |
0 | 2003-11-30 | 2010-11-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common | 1,703 | Indirect | ESOP under the 401(k) Savings Plan |
Common | 4,712 | Indirect | By GRAT |
Footnotes
- Gift
- Adjusted to reflect addition of 2,419 shares formerly held by GRAT.
- Adjusted to reflect two-for-one stock split in 2001.
- This transaction was executed in multiple trades at prices ranging from $59.78 to $59.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares acquired in the Johnson & Johnson Stock Fund under the 401(k) Savings Plan as of Plan's most recent reporting date (8/31/2010).
- Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (8/31/2010).
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- Adjusted to reflect deduction of 2,419 shares which were transferred into directly held shares.
- Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.